Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting analyst target cuts.
TD Cowen analyst Charles Rhyee lowered the firm’s price target on Cigna (CI) to $333 from $387 and keeps a Buy rating on the shares. The firm ...